北京大学学报(医学版) ›› 2016, Vol. 48 ›› Issue (4): 612-617. doi: 10.3969/j.issn.1671-167X.2016.04.009

• 论著 • 上一篇    下一篇

代谢相关因素与肾细胞癌分级、分期的相关研究

杜依青1,刘慧鑫1,刘春雷2,顿耀军1,李清1,于路平1,刘士军1,陈黎黎2,王晓峰1,徐涛1△   

  1. (1. 北京大学人民医院泌尿外科, 北京100044; 2. 青岛市中心医院泌尿外科, 山东青岛266042)
  • 出版日期:2016-08-18 发布日期:2016-08-18
  • 通讯作者: 徐涛 E-mail:xutao@medmail.com.cn
  • 基金资助:

    国家自然科学基金(31171341)资助

Analysis of metabolic factors and relevance with the grade and stage in patients with renal cell carcinoma

DU Yi-qing1, LIU Hui-xin1, LIU Chun-lei2, DUN Yao-jun1, LI Qing1, YU Lu-ping1, LIU Shi-jun1, CHEN Li-li2, WANG Xiao-feng1, XU Tao1△   

  1. (1. Department of Urology, Peking University People’s Hospital, Beijing 100044, China; 2. Department of Urology, Qingdao Center Medical Group, Qingdao 266042, Shandong, China)
  • Online:2016-08-18 Published:2016-08-18
  • Contact: XU Tao E-mail:xutao@medmail.com.cn
  • Supported by:

    Supported by the National Natural Science Foundation of China (31171341)

摘要:

目的:探讨肾细胞癌患者代谢相关因素与分级、分期等肿瘤病理学特征的相关性。方法:回顾性分析2009年1月至2015年1月期间在北京大学人民医院泌尿外科经手术后病理确诊的382例肾癌患者的病历资料,采用t检验、秩和检验和Logistic回归分析等多种统计学方法,分析常用代谢相关指标(体重、体质指数、腰围、血压、血糖、血清甘油三酯、胆固醇、低密度脂蛋白胆固醇和高密度脂蛋白胆固醇)与肾癌分级、分期及肿瘤直径的相关性。结果:382例患者中80例(20.94%)为高级别肿瘤,63例(16.49%)为进展性肿瘤,153例(40.05%)肿瘤直径>4 cm。与低级别肿瘤组相比,高级别肿瘤组患者的高密度脂蛋白胆固醇水平较低(P=0.015);进展性肿瘤患者与局限性患者相比具有较低的体质指数(P=0.022)、血清胆固醇(P=0.005)和高密度脂蛋白胆固醇(P=0.006);肿瘤直径>4 cm组的患者则具有较低的低密度脂蛋白胆固醇水平(P=0.030)。Logistic回归分析显示,体质指数(OR=0.906,95%CI: 0.852~0.986,P=0.023)、血清胆固醇(OR=0.660,95%CI: 0.492~0.884,P=0.005)与肿瘤分期相关,高密度脂蛋白胆固醇与肿瘤分级(OR=0.293,95%CI: 0.108~0.797,P=0.016)和分期(OR=0.204,95%CI: 0.065~0.635,P=0.006)均相关,低密度脂蛋白胆固醇与肿瘤直径相关(OR=0.756,95%CI: 0.586~0.975,P=0.031)。结论:代谢相关因素尤其是肥胖和血脂水平与肾癌分级、分期等组织病理学特征关系密切。

关键词: 癌, 肾细胞, 肥胖, 血脂异常, 病理学, 临床

Abstract:

Objective:To investigate the association between metabolic factors, such as obesity, blood pressure, blood glucose, serum lipid profile, and the histopathological characteristics of renal cell carcinoma. Methods: The medical records of 382 consecutive renal cell carcinoma patients who underwent radical or partial nephrectomy at Peking University People’s Hospital from January 2009 to January 2015 were retrospectively reviewed. Metabolic factors were collected from the records, including weight, body mass index, waist circumstance, blood pressure, fasting blood glucose, serum total triglyceride, serum total cholesterol, serum low-density lipoprotein-cholesterol and serum high-density lipoprotein-cholesterol. The patients were divided into different groups according to tumor grade, stage and diameter. Statistics analysis, such as t test, Mann-Whitney U test and Logistic analysis, were performed to investigate the association between metabolic factors and grade, stage and tumor diameter of renal cell carcinoma.  Results: A total of 80 (20.94%) of the tumors were classified as high grade disease, 63 (16.49%) were classified as advanced disease and 153 (40.05%) tumor diameter more than 4 cm. The patients in high grade group were found to have lower high-density lipoprotein-cholesterol level than in low grade group (P=0.015), body mass index, total cholesterol and high-density lipoprotein-cholesterol were found to be lower in advanced disease than in localized disease (P=0.022, P=0.005 and P=0.006, respectively), and low-density lipoprotein-cholesterol was found to be lower in larger tumors (P=0.030). Other factors were comparable between the different groups. The results of Logistic analyses showed that, body mass index (OR=0.906, 95%CI: 0.852-0.986, P=0.023) and total cholesterol (OR=0.660, 95%CI: 0.492-0.884, P=0.005) were associated with the tumor stage, high-density lipoprotein-cholesterol level was significantly associated with tumor grade (OR=0.293, 95%CI: 0.108-0.797, P=0.016) and stage (OR=0.204, 95%CI: 0.065-0.635, P=0.006), and low-density lipoprotein-cholesterol level was significantly associated with tumor diameter (OR=0.756, 95%CI: 0.586-0.975, P=0.031). Conclusion: The results of our study indicate that metabolic factors, especially obesity and serum lipid profile, are closely related with the histopathological characteristics of renal cell carcinoma.

Key words: Carcinoma, renal cell, Obesity, Dyslipidemias, Pathology, clinical

中图分类号: 

  • R737.11
[1] 黄教悌,胡菁,韩博. 治疗相关神经内分泌前列腺癌机制研究与靶向治疗新进展[J]. 北京大学学报(医学版), 2024, 56(4): 557-561.
[2] 张树栋,谢睿扬. 机器人手术时代的肾癌合并腔静脉瘤栓治疗策略[J]. 北京大学学报(医学版), 2024, 56(4): 562-564.
[3] 邢念增,王明帅,杨飞亚,尹路,韩苏军. 前列腺免活检创新理念的临床实践及其应用前景[J]. 北京大学学报(医学版), 2024, 56(4): 565-566.
[4] 田宇轩,阮明健,刘毅,李德润,吴静云,沈棋,范宇,金杰. 双参数MRI改良PI-RADS评分4分和5分病灶的最大径对临床有意义前列腺癌的预测效果[J]. 北京大学学报(医学版), 2024, 56(4): 567-574.
[5] 颜野,李小龙,夏海缀,朱学华,张羽婷,张帆,刘可,刘承,马潞林. 前列腺癌根治术后远期膀胱过度活动症的危险因素[J]. 北京大学学报(医学版), 2024, 56(4): 589-593.
[6] 于书慧,韩佳凝,钟丽君,陈聪语,肖云翔,黄燕波,杨洋,车新艳. 术前盆底肌电生理参数对前列腺癌根治性切除术后早期尿失禁的预测价值[J]. 北京大学学报(医学版), 2024, 56(4): 594-599.
[7] 刘帅,刘磊,刘茁,张帆,马潞林,田晓军,侯小飞,王国良,赵磊,张树栋. 伴静脉癌栓的肾上腺皮质癌的临床治疗及预后[J]. 北京大学学报(医学版), 2024, 56(4): 624-630.
[8] 舒帆,郝一昌,张展奕,邓绍晖,张洪宪,刘磊,王国良,田晓军,赵磊,马潞林,张树栋. 肾部分切除术治疗囊性肾癌的功能学和肿瘤学结果:单中心回顾性研究[J]. 北京大学学报(医学版), 2024, 56(4): 667-672.
[9] 周泽臻,邓绍晖,颜野,张帆,郝一昌,葛力源,张洪宪,王国良,张树栋. 非转移性T3a肾细胞癌患者3年肿瘤特异性生存期预测[J]. 北京大学学报(医学版), 2024, 56(4): 673-679.
[10] 陈敬,单蕊,肖伍才,张晓蕊,刘峥. 青春期和成年早期自制力与抑郁症状和超重肥胖共病风险的关联:基于全国调查的十年前瞻性队列研究[J]. 北京大学学报(医学版), 2024, 56(3): 397-402.
[11] 吴一凡,玉应香,谢岚,张志达,常翠青. 不同体重指数青年男性的静息能量消耗特点及预测方程评价[J]. 北京大学学报(医学版), 2024, 56(2): 247-252.
[12] 赖展鸿,李嘉辰,贠泽霖,张永刚,张昊,邢晓燕,邵苗,金月波,王乃迪,李依敏,李玉慧,栗占国. 特发性炎性肌病完全临床应答相关因素的单中心真实世界研究[J]. 北京大学学报(医学版), 2024, 56(2): 284-292.
[13] 苏俊琪,王晓颖,孙志强. 舌鳞状细胞癌根治性切除术后患者预后预测列线图的构建与验证[J]. 北京大学学报(医学版), 2024, 56(1): 120-130.
[14] 徐训敏,邵校,姬爱平. 口腔急诊科死亡病例分析[J]. 北京大学学报(医学版), 2024, 56(1): 185-189.
[15] 冯璐,翟佳羽,赵金霞. IgG4相关性疾病患者就诊情况及其临床特征[J]. 北京大学学报(医学版), 2023, 55(6): 1028-1032.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!